Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) Director William E. Bindley sold 651,454 shares of the company's stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total transaction of $13,133,312.64. Following the completion of the sale, the director now owns 1,939,817 shares in the company, valued at approximately $39,106,710.72. This trade represents a 25.14% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Guardian Pharmacy Services Trading Up 2.3%
Shares of Guardian Pharmacy Services stock traded up $0.49 during trading hours on Tuesday, reaching $21.78. The company's stock had a trading volume of 290,686 shares, compared to its average volume of 169,453. The company's 50 day simple moving average is $23.18 and its 200 day simple moving average is $22.01. Guardian Pharmacy Services, Inc. has a one year low of $14.16 and a one year high of $26.91.
Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The firm had revenue of $329.31 million for the quarter, compared to the consensus estimate of $321.21 million. On average, equities analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.
Wall Street Analyst Weigh In
Several analysts recently weighed in on GRDN shares. Raymond James set a $28.00 price objective on Guardian Pharmacy Services and gave the company an "outperform" rating in a report on Wednesday, May 14th. Truist Financial reiterated a "buy" rating and issued a $28.00 price target (up from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th. Finally, Wall Street Zen lowered Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th.
Get Our Latest Analysis on GRDN
Institutional Investors Weigh In On Guardian Pharmacy Services
A number of hedge funds have recently added to or reduced their stakes in the stock. R Squared Ltd bought a new stake in Guardian Pharmacy Services during the 4th quarter valued at $30,000. BNP Paribas Financial Markets acquired a new stake in Guardian Pharmacy Services during the fourth quarter valued at approximately $37,000. Compass Financial Services Inc purchased a new position in Guardian Pharmacy Services in the 4th quarter worth about $58,000. JPMorgan Chase & Co. acquired a new stake in Guardian Pharmacy Services during the 4th quarter valued at $77,000. Finally, Quantbot Technologies LP acquired a new stake in Guardian Pharmacy Services during the 4th quarter worth about $81,000.
About Guardian Pharmacy Services
(
Get Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Further Reading
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
